- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing SL Pharmaceutical Co Ltd (002038)
Beijing SL Pharmaceutical Co Ltd stock price live, this page displays SZ 002038 stock exchange data. View the 002038 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beijing SL Pharmaceutical Co Ltd real time stock price chart below.
What Is the Beijing SL Pharmaceutical Co Ltd Stock Price Today?
The Beijing SL Pharmaceutical Co Ltd stock price today is 6.46.
What Is the Stock Symbol for Beijing SL Pharmaceutical Co Ltd?
The stock symbol for Beijing SL Pharmaceutical Co Ltd is "002038."
What Stock Exchange Does Beijing SL Pharmaceutical Co Ltd Trade On?
Beijing SL Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Beijing SL Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Beijing SL Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002038 quote. (ISIN: CNE000001L31)
What Is the Beijing SL Pharmaceutical Co Ltd Stock Price Today?
The Beijing SL Pharmaceutical Co Ltd stock price today is 6.46.
What Is the Stock Symbol for Beijing SL Pharmaceutical Co Ltd?
The stock symbol for Beijing SL Pharmaceutical Co Ltd is "002038."
What Stock Exchange Does Beijing SL Pharmaceutical Co Ltd Trade On?
Beijing SL Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Beijing SL Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Beijing SL Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002038 quote. (ISIN: CNE000001L31)
Shenzhen
Currency in CNY
6.46
+0.01(+0.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.40
6.47
52 wk Range
5.98
8.74
002038 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.406.47
52 wk Range
5.988.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
002038 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Beijing SL Pharmaceutical Co Ltd Company Profile
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republic of China and internationally. The company’s finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; pegylated human granulocyte-stimulating factor injection; human granulocyte-cell stimulating factor injection; recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel; human interleukin-11; arsenic trioxide; thymopentin; paclitaxel injection; docetaxel injection; vinorelbine tartrate injection; asparaginase; calcium folinate; gemcitabine hydrochloride; regorafenib tablets; oseltamivir phosphate capsules; ornidazole injection; adefovir dipivoxil capsules/adefovir dipivoxil tablets; ribavirin; valacyclovir hydrochloride; levofloxacin hydrochlorid; tenofovir disoproxil fumarate; cyclosporin injection/cyclosporin soft capsules; mycophenolate mofetil dispersible; coenzyme complex; enoxaparin sodium; simvastatin; telmisartan amlodipine; liposon; nitroglycerin spray; eptifibatide, argatroban; voglibose; dapagliflozin; vildagliptin; granisetron hydrochloride injection; omeprazole enteric-coated capsules; adenosylmethionine butanedisulfonate; cytidine triphosphate disodium injection cytidine triphosphate disodium injection; gabapentin; risedronate sodium; salmon calcitonin injection; lucosamine sulfate capsules; loratadine dispersible; desloratadine; naftopidil; somatostatin for injection; octreotide acetate; and etodolac sustained-release tablets. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People’s Republic of China.
Compare 002038 to Peers and Sector
Metrics to compare | 002038 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002038PeersSector | |
|---|---|---|---|---|
P/E Ratio | 79.2x | 32.2x | −0.6x | |
PEG Ratio | −32.32 | −0.75 | 0.00 | |
Price/Book | 1.2x | 2.7x | 2.6x | |
Price / LTM Sales | 11.5x | 6.3x | 3.3x | |
Upside (Analyst Target) | - | 37.3% | 44.8% | |
Fair Value Upside | Unlock | 13.7% | 5.5% | Unlock |
Earnings
Latest Release
Oct 26, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
153.89M / --
FAQ
What Is the Sl Pharm A (002038) Stock Price Today?
The Sl Pharm A stock price today is 6.46 CNY.
What Stock Exchange Does Sl Pharm A Trade On?
Sl Pharm A is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Sl Pharm A?
The stock symbol for Sl Pharm A is "002038."
Does Sl Pharm A Pay Dividends? What’s The Current Dividend Yield?
The Sl Pharm A dividend yield is 0.31%.
What Is the Sl Pharm A Market Cap?
As of today, Sl Pharm A market cap is 6.64B CNY.
What Is Sl Pharm A's Earnings Per Share (TTM)?
The Sl Pharm A EPS (TTM) is 0.08.
From a Technical Analysis Perspective, Is 002038 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sl Pharm A Stock Split?
Sl Pharm A has split 8 times.
How Many Employees Does Sl Pharm A Have?
Sl Pharm A has 889 employees.
What is the current trading status of Sl Pharm A (002038)?
As of Feb 28, 2026, Sl Pharm A (002038) is trading at a price of 6.46 CNY, with a previous close of 6.45 CNY. The stock has fluctuated within a day range of 6.40 CNY to 6.47 CNY, while its 52-week range spans from 5.98 CNY to 8.74 CNY.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.